Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H13NO4 |
Molecular Weight | 211.2145 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
InChI
InChIKey=CJCSPKMFHVPWAR-JTQLQIEISA-N
InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1
Molecular Formula | C10H13NO4 |
Molecular Weight | 211.2145 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:57:41 UTC 2023
by
admin
on
Fri Dec 15 15:57:41 UTC 2023
|
Record UNII |
M4R0H12F6M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C02AB01
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
||
|
NDF-RT |
N0000175554
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
||
|
WHO-ATC |
C02LB01
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
||
|
NDF-RT |
N0000009918
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
||
|
WHO-ATC |
C02AB
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
38853
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
209-089-2
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
1545996
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB08867MIG
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
1110
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
M4R0H12F6M
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
218
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
DTXSID5023295
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
C175729
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
SUB26433
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
m7397
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | Merck Index | ||
|
555-30-6
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
M4R0H12F6M
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
DB00968
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
169916
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
METHYLDOPA
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY | |||
|
61058
Created by
admin on Fri Dec 15 15:57:41 UTC 2023 , Edited by admin on Fri Dec 15 15:57:41 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS | |||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
SUBSTANCE->BASIS OF STRENGTH |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
ACTIVE IN RATS
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
PARENT -> METABOLITE |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
Approximately 70 percent of the drug which is absorbed is excreted in the urine as methyldopa and its mono-0-sulfate conjugate
MAJOR
PLASMA; URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |